Ibon Martinez-Arranz
Overview
Explore the profile of Ibon Martinez-Arranz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
699
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Michelena J, Alonso C, Martinez-Arranz I, Altamirano J, Mayo R, Sancho-Bru P, et al.
Ann Hepatol
. 2019 May;
18(1):144-154.
PMID: 31113584
Introduction And Aims: Alcoholic hepatitis is the most severe manifestation of alcoholic liver disease. Unfortunately, there are still some unresolved issues in the diagnosis and management of this disease, such...
12.
Herreros-Villanueva M, Duran-Sanchon S, Martin A, Perez-Palacios R, Vila-Navarro E, Marcuello M, et al.
Clin Transl Gastroenterol
. 2019 Mar;
10(3):e00031.
PMID: 30913126
No abstract available.
13.
Herreros-Villanueva M, Duran-Sanchon S, Martin A, Perez-Palacios R, Vila-Navarro E, Marcuello M, et al.
Clin Transl Gastroenterol
. 2019 Feb;
10(1):e00003.
PMID: 30702491
Objectives: Specific microRNA (miRNA) signatures in biological fluids can facilitate earlier detection of the tumors being then minimally invasive diagnostic biomarkers. Circulating miRNAs have also emerged as promising diagnostic biomarkers...
14.
Reverter E, Lozano J, Alonso C, Berzigotti A, Seijo S, Turon F, et al.
Liver Int
. 2019 Jan;
39(4):705-713.
PMID: 30637923
Background: In cirrhosis, a decrease in hepatic venous pressure gradient (HVPG) > 10% after acute iv propranolol (HVPG response) is associated with a lower risk of decompensation and death. Only...
15.
Morrison M, Verschuren L, Salic K, Verheij J, Menke A, Wielinga P, et al.
Hepatol Commun
. 2018 Dec;
2(12):1513-1532.
PMID: 30556039
Concerns have been raised about whether preclinical models sufficiently mimic molecular disease processes observed in nonalcoholic steatohepatitis (NASH) patients, bringing into question their translational value in studies of therapeutic interventions...
16.
Banales J, Inarrairaegui M, Arbelaiz A, Milkiewicz P, Muntane J, Munoz-Bellvis L, et al.
Hepatology
. 2018 Oct;
70(2):547-562.
PMID: 30325540
Early and differential diagnosis of intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC) by noninvasive methods represents a current clinical challenge. The analysis of low-molecular-weight metabolites by new high-throughput techniques is...
17.
Cubiella J, Clos-Garcia M, Alonso C, Martinez-Arranz I, Perez-Cormenzana M, Barrenetxea Z, et al.
Cancers (Basel)
. 2018 Sep;
10(9).
PMID: 30200467
Low invasive tests with high sensitivity for colorectal cancer and advanced precancerous lesions will increase adherence rates, and improve clinical outcomes. We have performed an ultra-performance liquid chromatography/time-of-flight mass spectrometry...
18.
Mayo R, Crespo J, Martinez-Arranz I, Banales J, Arias M, Minchole I, et al.
Hepatol Commun
. 2018 Jul;
2(7):807-820.
PMID: 30027139
Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease worldwide and includes a broad spectrum of histologic phenotypes, ranging from simple hepatic steatosis or nonalcoholic...
19.
Bril F, Millan L, Kalavalapalli S, McPhaul M, Caulfield M, Martinez-Arranz I, et al.
Diabetes Obes Metab
. 2018 Mar;
20(7):1702-1709.
PMID: 29527789
Aims: To assess the utility of existing metabolomics scores to classify liver disease in patients with type 2 diabetes mellitus (T2DM). Materials And Methods: A total of 220 patients with...
20.
Iruarrizaga-Lejarreta M, Varela-Rey M, Fernandez-Ramos D, Martinez-Arranz I, C Delgado T, Simon J, et al.
Hepatol Commun
. 2017 Nov;
1(9):911-927.
PMID: 29159325
Conclusions: Aramchol treatment improved steatohepatitis and fibrosis by 1) decreasing SCD1, and 2) increasing the flux through the transsulfuration pathway maintaining cellular redox homeostasis. We also demonstrated that the 0.1MCD...